STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Recursion Pharmaceuticals (RXRX) insider files notice to sell 100,000 Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Recursion Pharmaceuticals, Inc. (symbol RXRX) reports a planned sale of 100,000 Class A shares through Fidelity Brokerage Services LLC on NASDAQ, dated August 13, 2026, at a listed value of $331,000.00. These are identified as founders shares originally acquired on April 20, 2021 as compensation.

The notice also lists multiple Class A share transactions during the prior three months involving Christopher C. Gibson, Gibson Family Trust, and Lahwran-3 LLC, including individual transactions such as 340,440 shares for $1,089,541.29 on June 18, 2026 and several additional trades in July and August 2026.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 100000 Class A shares Listed in planned transaction through Fidelity Brokerage Services LLC
Listed value of planned sale $331,000.00 Value associated with 100,000 Class A shares for August 13, 2026
Planned sale date 08/13/2026 Date associated with the 100,000 Class A shares on NASDAQ
Large prior trade 340,440 shares for $1,089,541.29 Christopher C. Gibson Class A sale on 06/18/2026
Example July trade 100,000 shares for $390,028.58 Christopher C. Gibson Class A sale on 07/07/2026
Trust transaction 50,000 shares for $195,014.41 Gibson Family Trust Class A sale on 07/07/2026
founders shares financial
"Class A | 04/20/2021 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
compensation financial
"100000 | 04/20/2021 | Compensation"
Fidelity Brokerage Services LLC financial
"Class A | Fidelity Brokerage Services LLC 900 Salem Street"
Class A financial
"Class A | 05/22/2026 | 40000 | 123200.00"
Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.
Gibson Family Trust financial
"Gibson Family Trust 41 S Rio Grande Street Salt Lake City"
Lahwran-3 Llc financial
"Lahwran-3 Llc 41 S Rio Grande Street Salt Lake City"

FAQ

What does the RXRX Form 144 notice disclose about planned share sales?
The notice discloses a planned sale of 100,000 Class A shares of Recursion Pharmaceuticals, Inc. at a listed value of $331,000.00, to be executed through Fidelity Brokerage Services LLC on August 13, 2026 on NASDAQ.

Who is involved in the planned RXRX Class A share sale?
The planned sale involves Class A common stock of Recursion Pharmaceuticals, Inc., to be handled by Fidelity Brokerage Services LLC as broker, with 100,000 shares listed for potential sale on NASDAQ on August 13, 2026.

What are the characteristics of the RXRX founders shares mentioned?
The filing identifies the securities as Class A founders shares of Recursion Pharmaceuticals, Inc., originally acquired from the issuer on April 20, 2021 as compensation, with 100,000 shares described in the current planned sale section.

What prior RXRX share transactions are listed in the last three months?
The notice lists multiple Class A share transactions over three months involving Christopher C. Gibson, Gibson Family Trust, and Lahwran-3 LLC, including a trade of 340,440 shares for $1,089,541.29 on June 18, 2026 and several 100,000-share trades in July 2026.

On which market are the RXRX shares in this notice expected to trade?
The shares covered by the notice are indicated for trading on NASDAQ, with the planned 100,000 Class A shares routed through Fidelity Brokerage Services LLC and a listed transaction date of August 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR